Status:
RECRUITING
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Lead Sponsor:
University Hospital, Rouen
Conditions:
Hepatitis B
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users
Eligibility Criteria
Inclusion Criteria:
- Former or active intravenous and/or nasal drug user
- Person on opiate substitution therapy
Exclusion Criteria:
- Person with known active viral infection(s)
Key Trial Info
Start Date :
December 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05390424
Start Date
December 2 2022
End Date
January 1 2027
Last Update
February 17 2026
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Caarud Sud Manche
Avranches, France, 50300
2
Csapa Barentin
Barentin, France, 76360
3
Oeuvre Normande Des Meres
Dieppe, France, 76200
4
Csapa Act
Elbeuf, France, 76500